Does high-sensitivity c-reactive protein or low-density lipoprotein cholesterol show a stronger relationship with the cardio-ankle vascular index in healthy community dwellers?: The KOBE study

Journal of Atherosclerosis and Thrombosis

Volumn 19, Issue 11, 2012, Pages 1027-1034

  Higashiyama, Aya ^a,b   Wakabayashi, Ichiro ^a   Kubota, Yoshimi ^b   Adachi, Yoshiko ^a   Hayashibe, Akiko ^a   Nishimura, Kunihiro ^b,c   Sugiyama, Daisuke ^b,d   Kadota, Aya ^b,e   Imano, Hironori ^b,f   Miyamatsu, Naomi ^b,e   Miyamoto, Yoshihiro ^b,c   Okamura, Tomonori ^b,d  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b FOUNDATION FOR BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

^c NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^d KEIO UNIVERSITY   (Japan)

^e SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^f OSAKA UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Community based study; Epidemiology; Inflammation

Indexed keywords

C REACTIVE PROTEIN; HIGH SENSITIVITY C REACTIVE PROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; UNCLASSIFIED DRUG;

ADULT; AGED; ANALYSIS OF COVARIANCE; ARTICLE; ATHEROSCLEROSIS; CARDIO ANKLE VASCULAR INDEX; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; COMMUNITY LIVING; CONTROLLED STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; JAPAN; LINEAR REGRESSION ANALYSIS; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; NORMAL HUMAN; RISK ASSESSMENT;

AGED; ANKLE; C-REACTIVE PROTEIN; CARDIOVASCULAR SYSTEM; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; JAPAN; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; REFERENCE VALUES;

EID: 84870730152     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.13599     Document Type: Article

References (23)

1. Pekkanen J, Linn S, Heiss G, Suchindran CM, Leon A, Rifkind BM, Tyroler HA: Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. N Engl J Med,1990; 322: 1700-1707
2. Okamura T, Kokubo Y, Watanabe M, Higashiyama A, Miyamoto Y, Yoshimasa Y, Okayama A: Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort study: The Suita study. Atherosclerosis, 2009; 203: 587-592
3. Ridker PM: Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation, 2003; 107: 363-369
4. Iso H, Cui R, Date C, Kikuchi S, Tamakoshi A; JACC Study Group: C-reactive protein levels and risk of mortality from cardiovascular disease in Japanese: the JACC Study. Atherosclerosis, 2009; 207: 291-297
5. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR: Comparison of C-reactive protein and low-density lipoprotein levels in the prediction of first cardiovascular events. N Engl J Med, 2002; 347: 1557-1565
6. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastellein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ: Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med, 2008; 359: 2195-2207
7. Libby P, Ridker PM: Inflammation and atherosclerosis: Role of C-reactive protein in risk assessment. Am J Med, 2004; 116: 9S-16S
8. Ueshima H: Explanation for Japanese paradox: prevention of increase in coronary heart disease and reduction in stroke. J Atheroscler Thromb, 2007; 14: 278-286
9. El-Saed A, Curb JD, Kadowaki T, Okamura T, Sutton-Tyrrell K, Masaki K, Seto TB, Takamiya T, Choo J, Edmundowicz D, Evans RW, Fujiyoshi A, Nakamura Y, Miura K, Shin C, Kuller LH, Ueshima H, Sekikawa A: The prevalence of aortic calcification in Japanese compared to white and Japanese-American middle-aged men is confounded by the amount of cigarette smoking. Int J Cardiol, 2012, in press
10. Yamada S, Gotoh T, Nakashima Y, Kayaba K, Ishikawa S, Nago N, Nakamura Y, Itoh Y, Kaiji E: Distribution of serum C-reactive protein and its atherosclerotic risk factors in a Japanese population: Jichi Medical School Cohort Study. Am J Epidemiol, 2001; 153: 1183-1190
11. Noike H, Nakamura K, Sugiyama Y, Iizuka T, Shimizu K, Takahashi M, Hirano K, Suzuki M, Mikamo H, Nakagami T, Shirai K: Changes in cardio-ankle vascular index in smoking cessation. J Atheroscler Thromb, 2010; 17: 517-525
12. Shirai K, Hiruta N, Song M, Kurosu T, Suzuki J, Tomaru T, Miyashita Y, Saiki A, Takahashi M, Suzuki K, Takata M: Cardio-ankle vascular index (CAVI) as a novel indicator of arterial stiffness: theory, evidence and perspectives. J Atheroscler Thromb, 2011; 18: 924-938
13. Nakamura K, Tomaru T, Yamamura S, Miyashita Y, Shirai K, Noike H: Cardio-ankle vascular index is a candidate predictor of coronary atherosclerosis. Circ J, 2008; 72: 598-604
14. Izuhara M, Shioji K, Kadota S, Baba O, Takeuchi Y, Uegaito T, Mutsuo S, Matsuda M: Relationship of cardio-ankle vascular index (CAVI) to carotid and coronary arteriosclerosis. Circ J, 2008; 72: 1762-1767
15. Miyoshi T, Doi M, Hirohata S, Sakane K, Kamikawa S, Kitawaki T, Kaji Y, Kusano KF, Ninomiya Y, Kusachi S: Cardio-ankle vascular index is independently associated with the severity of coronary atherosclerosis and left ventricular function in patients with ischemic heart disease. J Atheroscler Thromb, 2010; 17: 249-258
16. Kadota K, Takamura N, Aoyagi K, Yamasaki H, Usa T, Nakazato M, Maeda T, Wada M, Nakashima K, Abe K, Takeshima F, Ozono Y: Availability of cardio-ankle vascular index (CAVI) as a screening tool for atherosclerosis. Circ J, 2008; 72: 304-308
17. Teramoto T, Sasaki J, Ueshima H, Egusa G, Kinoshita M, Shimamoto K, Daida H, Biro S, Hirobe K, Funahashi T, Yokote K, Yokode M; Japan Atherosclerosis Society (JAS) Committee for Epidemiology and Clinical Management of Atherosclerosis: Diagnostic criteria for dyslipidemia. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese. J Atheroscler Thromb, 2007; 14: 155-158
18. Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, Imai Y, Imaizumi T, Ito S, Iwao H, Kario K, Kawano Y, Kim-Mitsuyama S, Kimura G, Matsubara H, Matsuura H, Naruse M, Saito I, Shimada K, Shimamoto K, Suzuki H, Takishita S, Tanahashi N, Tsuchihashi T, Uchiyama M, Ueda S, Ueshima H, Umemura S, Ishimitsu T, Rakugi H; Japanese Society of Hypertension Committee: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res, 2009; 32: 3-107
19. American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care, 2010; 33 (suppl 1): S11-S61
20. CY Li, FC Sung: A review of the healthy worker effect in occupational epidemiology. Occup. Med, 1999; 49: 225-229
21. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr, Taubert K, Tracy RP, Vinicor F; Centers for Disease Control and Prevention; American Heart Association: Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation, 2003; 107: 499-511
22. Miyashita Y, Endo K, Saiki A, Ban N, Nagumo A, Yamaguchi T, Kawana H, Nagayama D, Ohira M, Oyama T, Shirai K: Effect of Ezetimibe monotherapy on lipid metabolism and arterial stiffness assessed by Cardio-Ankle Vacular Index in type 2 diabetic patients. J Atheroscler Thromb, 2010; 17: 1070-1076
23. Inoue N, Okamura T, Kokubo Y, Fujita Y, Sato Y, Nakanishi M, Yanagida K, Kakino A, Iwamoto S, Watanabe M, Ogura S, Otsui K, Matsuda H, Uchida K, Yoshimoto R, Sawamura T: LOX index, a novel predictive biochemical marker for coronary heart disease and stroke. Clin Chem, 2010; 56: 550-558